secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001193125-23-011170
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical announces departure of CFO Michael Holder and COO Kathy McGee, appoints Sean Ekins as interim CFO
--------------------------------------------------------------------------------

- CFO Michael Holder and COO Kathy McGee leaving Avita Medical effective Jan 19, 2023.
- Sean Ekins, SVP of Finance, appointed interim CFO; company will search for permanent CFO.
- COO role discontinued; product development, operations, regulatory report directly to CEO James Corbett.
- Holder and McGee receive severance: 12 months base salary, health benefits, stock acceleration; McGee also gets 2022 bonus of $164,140.
- Company will report Q4 2022 earnings on Feb 23, 2023, and provide revenue guidance for Q1 and full year 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523011170/0001193125-23-011170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523011170/d416307d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-011170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer